Wenxue Ma

10PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersMolecular targetsLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 16, 2026
Perioperative circulating tumor DNA profiling for recurrence risk in esophageal squamous cell carcinoma: moving toward a biology-driven surveillance model.

Emma Klacking, Wenxue Ma

|Sep 02, 2025
Chimeric Antigen Receptor-Macrophage Therapy Enters the Clinic: The First-in-Human Trial for HER2+ Solid Tumors.

Wenxue Ma, Catriona Jamieson

|Feb 03, 2024
Beyond blood: Advancing the frontiers of liquid biopsy in oncology and personalized medicine.

Ying Bao, Dejing Zhang, Huihui Guo

|Dec 23, 2023
Navigating the Immune Maze: Pioneering Strategies for Unshackling Cancer Immunotherapy Resistance.

Liqin Yao, Qingqing Wang, Wenxue Ma

|Dec 11, 2022
Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors.

Qiuqiang Chen, Lingeng Lu, Wenxue Ma

|Jul 25, 2022
Breast Cancer Patients: Who Would Benefit from Neoadjuvant Chemotherapies?

Liqin Yao, Gang Jia, Lingeng Lu

Pageof 2

Frequent Collaborators

2 joint publications

Lingeng Lu

1 joint publications

Sung Chang Lee

1 joint publications

Eric N Hampton

1 joint publications

Hwayoung Yun